WuXi now supports more than 3,400 small-molecule CDMO projects, with a growing share of Phase III and commercial-stage drugs.
(Bloomberg) -- WuXi AppTec Co. tumbled by an intraday record in Hong Kong, with traders attributing the decline to proposed US legislation that would ban the Chinese medical technology company and its ...
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$111.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock ...
WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and life sciences industry ...
WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling around 6,000 customers from over 30 countries to improve the health of ...
ET Net News Agency, 29 January 2026] A direct manual trade of 500,000 shares of WUXI APPTEC (02359) was registered at 1:02p.m. The deal amounted to HK$57.22m, or at HK$114.45 per ...
PHILADELPHIA and OXFORD, March 2, 2021 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device ...
(Bloomberg) -- Shares of WuXi Biologics Cayman Inc. and its sister company WuXi AppTec Co. gained in Hong Kong after a US lawmaker sponsoring a bill that would block the companies from federal ...
The pharmaceutical services company achieved top environmental scores from CDP for both climate action and water stewardship, ...
As new legislation stands to threaten the U.S. business of certain Chinese biopharma companies, CDMO giant WuXi AppTec has stepped in to make a case for itself. In an open letter signed by chairman ...
SHANGHAI, Aug. 5, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...
WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results